Navigation Links
FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements

SILVER SPRING, Md., May 13, 2011 /PRNewswire-USNewswire/ --  The following was released today by the FDA:


Fast Facts

  • The FDA is warning consumers not to use products marketed as dietary supplements that also claim to be antimicrobial (antibiotic, antifungal or antiviral) drugs. These illegal products are falsely promoted with claims to treat illnesses such as upper respiratory infections, sinusitis, pneumonia, bronchitis and the common cold.
  • The FDA has learned that several companies are distributing and promoting products labeled as dietary supplements for antimicrobial uses. These products may or may not contain antimicrobials, and their use could delay treatment for serious illnesses.
  • The FDA has determined that many of these products mimic the labeling of drugs available in Mexico, and that they are marketed specifically to the Hispanic community.
  • Consumers should stop using these products immediately and contact their health care providers.

  • What is the Problem?The FDA has determined that several companies are marketing products that look like antimicrobial products available in Mexico. Consumers using the products may believe they will receive the beneficial health effects of an antimicrobial drug. These products may or may not contain antimicrobials, and their use could delay treatment for serious illnesses.  These products are not FDA approved to treat, cure or prevent any medical conditions.

    What are the Symptoms of Illness/Injury?Consumers may be using these products under the belief that they contain antimicrobials. Doing so may cause worsening of existing illness and delayed treatment. An antimicrobial is a substance that kills or inhibits the growth of pathogens such as bacteria, viruses and fungi.

    The FDA is aware of at least four cases in Texas in which children received emergency care due to worsening illnesses after being given products that the parents may have believed contained antimicrobials. These products were packaged to resemble antimicrobial drugs that are readily available in Mexico.  It was determined the children had been given a product, Amoxilina, which the parents may have believed was the antimicrobial Amoxicillin. Giving the product to the children delayed legitimate medical treatment.

    Who is at Risk?All consumers are at risk. Although package labels are printed in English and Spanish, the packaging mimics antimicrobials readily available in Mexico and possibly familiar to Hispanic consumers. 

    What Do Consumers and Health Care Providers Need To Do?  

    Consumers who have been using these types of products should consult their health care providers immediately. Consumers should be skeptical of any product that claims to be a dietary supplement and claims to treat, prevent or cure disease or contain an antimicrobial.

    Health care professionals and consumers are encouraged to report serious adverse events (side effects) or product quality problems with the use of these products to the FDA's MedWatch Adverse Event Reporting program online, by regular mail, fax or phone.

  • Online:
  • Regular Mail: Use FDA postage paid form 3500 and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
  • Fax: 800-FDA-0178
  • Phone: 800-FDA-1088

  • What Does the Product Look Like? Various companies market these products. The FDA is aware of several products listed below, but this list may not be complete.Product Name


    UPC #

    StatusAmoxilina Capsules 500 Mg (30 Caps)



    Voluntarily recalled  05/06/2011Amoxilina Suspension (3.4 Oz)



    Voluntarily recalled  05/06/2011Pentreximil Plus 500 Mg (30 Caps)



    Voluntarily recalled  05/06/2011Pentreximil Plus Syrup 3.4 Oz



    Voluntarily recalled  05/06/2011Pentrexyl Forte Natural, 30-capsule box containing capsules in blister packs

    Phoenix Import & Distribution

    8 93843 00129 3

    Voluntarily recalled 05/12/11Where is it Distributed? The products have been distributed in Colorado, Delaware, Texas, Florida, California, Georgia, and potentially other markets. The products are marketed toward Hispanic consumers. They may be sold at various retailers, including small independent stores that cater to the Hispanic community.

    The information in this press release reflects the FDA's best efforts to communicate what it has learned from the manufacturer and the state and local public health agencies involved in the investigation. The agency will update this page as more information becomes available.

    For more information:

    Drug Claims Prompt Health Alert:

    Multi-Mex Recall Notice:

    Phoenix Recall Notice:

    Beware of Fraudulent "Dietary Supplements":

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


    Visit the FDA on Facebook

    RSS Feed for FDA News Releases [what is RSS?]

    Media Inquiries: Tamara Ward, 301-796-7567 (Office) 240-479-8003 (Cell)

    Consumer Inquiries: 888-INFO-FDA


    SOURCE U.S. Food and Drug Administration
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dr. Haroun Rostami, a Beverly Hills Prosthodontist, Provides Patients with Metal-Free Dentistry Treatments
    2. New Study Published: Lactobacillus reuteri Prodentis Effective in the Treatment of Periodontitis
    3. OrthoAccel Technologies Committed to Plans for Positioning the United Kingdom as a Key Strategic Market for New Orthodontic Technology
    4. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
    5. Imagenetix Announces Issuance of New U.S. Patent for the Prevention and Treatment of Periodontal Disease
    6. Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDAs Office of New Drugs
    7. Dramatic Price Increases in Brand Name Drugs Spur Shareholders to Action
    8. Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011
    9. Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants
    10. Bend Research Receives Patent for Technology That Enhances the Bioavailability of Low-Solubility Drugs
    11. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
    Post Your Comments:
    (Date:11/24/2015)... , Nov. 24, 2015 Avery Biomedical ... is pleased to announce the appointment of Anders ... Dr. Jonzon ... cardiology at Children,s Hospital, Uppsala University, Uppsala and Children,s ... 1984-1986, he was a fellow at the Cardiovascular Institute ...
    (Date:11/24/2015)... and BERN, Switzerland , November ... ARTORG Center for Biomedical Engineering Research of the University ... Division of Endocrinology, Diabetes and Clinical Nutrition of the ... start of an exclusive collaboration to develop a novel ... for the personalised delivery of insulin for diabetic patients ...
    (Date:11/24/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... and Human Resources will be presenting in the upcoming Atlantic ... Strategies for a Dynamic Market" on Dec. 1, 2015. Rice ... with the Cambridge Advisory Group, where she leads their pharmacy ... webinar will discuss the rapid growth of oral oncolytics, the ...
    Breaking Medicine Technology:
    (Date:11/24/2015)... Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... explored the different restrictions and variables that determine which patients are or are not ... those patients that have a BMI over 40, are more than 100 pounds overweight, ...
    (Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
    (Date:11/24/2015)... ... November 24, 2015 , ... ... share their knowledge and experiences at a live taping of the next ... for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University Hotel & ...
    (Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western Connecticut ... to detect and treat pancreatic cancer (PC). , WCHN researchers will focus on ... genetic material that is present in the blood of patients with PC. It ...
    (Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... award for its exceptional customer service: the TrustDale certification. The award recognizes good ... Baltimore stone honing , tile and grout, and hard surface restoration company ...
    Breaking Medicine News(10 mins):